MeMed

Rapid Infection Diagnostics | Bacterial vs Viral Test

MeMed was founded in 2009, is headquartered in Haifa, Israel, lists 51–200 employees, and has $181.1M in recorded funding across 4 rounds.

Headquarters
Haifa
Employees
51–200
Founded
2009
Business Model
B2B
Website
me-med.com
Total Funding
$181.1M
Last Round
$14.1M Growth EquityMay 2026
Rounds
4

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 4 funding rounds and 5 investors for this company. The full record is or through the API.

About

MeMed applies machine learning to translate complex immune-system signaling into actionable diagnostic insights for infectious diseases and inflammatory disorders. Its FDA-cleared MeMed BV host-immune response assay distinguishes bacterial from viral infections in 15 minutes. The compact MeMed Key immunoassay platform performs sensitive, rapid, multiplexed protein measurements, and together the products help physicians manage patients with acute infections.

Summary

MeMed is a Biotech company based in Haifa, Israel, founded in 2009. It lists 51–200 employees. It has raised $181.1M in total across 4 rounds, most recently a $14.1M Growth Equity round in May 2026. Investors include DGF Investimentos, BridgeOne and U.S. Department of Defense.

Tech & App Stack

4 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Growth EquityGrowth EquityMay 2026
$14.1M

Sign up to see all 4 events

Funding: Growth Equity through Series E. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

MeMed on Indexed.vc
<a href="https://indexed.vc/companies/memed"><img src="https://indexed.vc/api/badge/company/memed" alt="MeMed on Indexed.vc" width="260" height="76" /></a>